CPT® Code 87651

The CPT® Code 87651 refers to a laboratory test designed for the detection of the infectious agent known as Streptococcus, group A (GAS) through the use of nucleic acid amplification techniques. This test specifically targets the DNA or RNA of the bacterium, which is crucial for diagnosing infections caused by GAS. Streptococcus, group A is primarily transmitted through respiratory droplets and direct contact with infected skin lesions, such as those seen in impetigo. Additionally, there have been instances of transmission through contaminated food and water. The clinical manifestations of GAS infections are diverse, commonly presenting as respiratory infections and skin infections, but they can also lead to more severe conditions such as meningitis, osteomyelitis, toxic shock syndrome, and necrotizing fasciitis. The test utilizes an amplified probe technique, which significantly enhances the sensitivity of the assay. This is achieved by exponentially amplifying the target nucleic acid sequence of the GAS, allowing for the detection of even minute quantities of the pathogen. The amplification process typically employs polymerase chain reaction (PCR) or reverse transcriptase polymerase chain reaction (RT-PCR) methods. During the testing process, a sample is treated to release nucleic acids from the target organism, if present. A labeled probe, which is designed to bind specifically to the target sequence, is then introduced. This probe is often labeled with fluorescent or chemiluminescent markers, enabling the identification of the hybrid formed between the probe and the target sequence. The amplified sequences can also be quantified, providing valuable information regarding the load of the microorganism present in the sample, which is essential for assessing the severity of the infection and guiding treatment decisions.